2013
DOI: 10.18632/aging.100573
|View full text |Cite
|
Sign up to set email alerts
|

Rapamycin suppresses brain aging in senescence-accelerated OXYS rats

Abstract: Cellular and organismal aging are driven in part by the MTOR (mechanistic target of rapamycin) pathway and rapamycin extends life span in C elegans, Drosophila and mice. Herein, we investigated effects of rapamycin on brain aging in OXYS rats. Previously we found, in OXYS rats, an early development of age-associated pathological phenotypes similar to several geriatric disorders in humans, including cerebral dysfunctions. Behavioral alterations as well as learning and memory deficits develop by 3 months. Here w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
34
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
8
2

Relationship

2
8

Authors

Journals

citations
Cited by 60 publications
(38 citation statements)
references
References 27 publications
4
34
0
Order By: Relevance
“…BCCAo also induced a reduction in spontaneous locomotion specifically in the Nfkb1-deficient female mice. Similarly, a strain of senescenceaccelerated OXYS rats has been reported to exhibit a dramatic decrease in open field rearing [50].…”
Section: Discussionmentioning
confidence: 96%
“…BCCAo also induced a reduction in spontaneous locomotion specifically in the Nfkb1-deficient female mice. Similarly, a strain of senescenceaccelerated OXYS rats has been reported to exhibit a dramatic decrease in open field rearing [50].…”
Section: Discussionmentioning
confidence: 96%
“…Although neurodegenerative changes were also observed in OXYS rats even at the young age of 3 months [37,38], they were localized mainly in the cortical area while the size of hippocampus was even increased. The latter may evidence compensatory mechanisms that explain the absence of significant changes in olfactory function.…”
Section: Discussionmentioning
confidence: 87%
“…Rapamycin causes a brain area-dependent reduction of sarkosyl insoluble tau levels, and a marked increase of autophagy markers [80]. Rapamycin, when given at a low dosage between 1.5 and 3.5 months of age, reduces total tau levels and p-Ser181 tau levels in OXYS rats, and increases total S6K1 and p-S6K1 levels [81].…”
Section: Mtorc1mentioning
confidence: 99%